Compare ZURA & STRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZURA | STRW |
|---|---|---|
| Founded | 2022 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.2M | 151.1M |
| IPO Year | N/A | N/A |
| Metric | ZURA | STRW |
|---|---|---|
| Price | $3.51 | $13.09 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 4 |
| Target Price | $11.38 | ★ $12.72 |
| AVG Volume (30 Days) | ★ 408.9K | 28.2K |
| Earning Date | 11-13-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 4.92% |
| EPS Growth | N/A | ★ 19.41 |
| EPS | N/A | ★ 0.61 |
| Revenue | N/A | ★ $145,392,000.00 |
| Revenue This Year | N/A | $33.39 |
| Revenue Next Year | N/A | $5.21 |
| P/E Ratio | ★ N/A | $21.40 |
| Revenue Growth | N/A | ★ 29.76 |
| 52 Week Low | $0.97 | $8.70 |
| 52 Week High | $4.68 | $13.24 |
| Indicator | ZURA | STRW |
|---|---|---|
| Relative Strength Index (RSI) | 44.69 | 71.82 |
| Support Level | $3.57 | $12.30 |
| Resistance Level | $3.95 | $12.27 |
| Average True Range (ATR) | 0.27 | 0.37 |
| MACD | -0.07 | 0.12 |
| Stochastic Oscillator | 0.43 | 90.96 |
Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is developing a portfolio of therapeutic indications for tibulizumab and torudokimab with a goal of demonstrating their efficacy, safety, and dosing convenience in autoimmune and inflammatory diseases.
Strawberry Fields REIT Inc is a self-managed and self-administered company that specializes in the acquisition, ownership and triple-net leasing of skilled nursing facilities and other post-acute healthcare properties.